Cargando…
Two cases of delayed onset of immune‐related adverse events after discontinuation of nivolumab in patients with metastatic renal cell cancer
INTRODUCTION: Delayed onset of immune‐related adverse events following immune‐checkpoint inhibitor discontinuation is underrecognized because of little available evidence. CASE PRESENTATION: A 50‐year‐old man with metastatic renal cell carcinoma (Case 1) and 58‐year‐old woman with renal cell carcino...
Autores principales: | Nakai, Yasutomo, Otsuka, Tomoyuki, Inoue, Takako, Nawa, Takatoshi, Hatano, Koji, Yamamoto, Yoshiyuki, Nagahara, Akira, Nakayama, Masashi, Kakimoto, Ken‐ichi, Nishimura, Kazuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8413213/ https://www.ncbi.nlm.nih.gov/pubmed/34497995 http://dx.doi.org/10.1002/iju5.12338 |
Ejemplares similares
-
Renal cell carcinoma with central nervous system demyelination caused by nivolumab
por: Oka, Toshiki, et al.
Publicado: (2020) -
Advanced adrenocortical carcinoma successfully treated with gemcitabine plus capecitabine as second‐line chemotherapy
por: Yamamoto, Akinaru, et al.
Publicado: (2020) -
Solitary fibrous tumor mimicking adrenal tumor concomitant with contralateral adrenal pheochromocytoma: A case report of surgical resection after long-term observation
por: Kuribayashi, Sohei, et al.
Publicado: (2019) -
Partial nephrectomy for a Bosniak IV cystic renal mass mimicking a simple renal cyst adjacent to a solid renal tumor
por: Oka, Toshiki, et al.
Publicado: (2020) -
Efficacy and safety of mycophenolate mofetil in treating immune‐related hepatitis induced by immune checkpoint inhibitor use: A retrospective study
por: Kadokawa, Yukio, et al.
Publicado: (2023)